mass 451.475 g/molPharmacokinetic cardura medicament 65%Protein binding 98%Metabolism HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ? cardura medicament onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is Carduran®.

The primary effect of this blockage is relaxed vascular smooth muscle tone (vasodilation), which decreases cardura medicament vascular resistance, leading to cardura medicament blood pressure. DoxazosinFrom Wikipedia, the free encyclopedia(Redirected from Cardura)Jump cardura medicament navigation, searchDoxazosinSystematic (IUPAC) name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS number 74191-85-8ATC code C02CA04PubChem 3157DrugBank APRD00474Chemical dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein binding 98%Metabolism HepaticHalf life cardura medicament hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold cardura medicament Pfizer under the brand names Cardura® and Carduran® , is an alpha-1 adrenergic cardura medicament blocker which inhibits the binding of norepinephrine to alpha receptors in the autonomic nervous system. The primary effect of this blockage of.

mesylate, a quinazoline compound sold by Pfizer under the cardura medicament names Cardura® and Carduran® , is an alpha-1 adrenergic receptor.